Send to a Friend Font Size: Increase Decrease

ALT and XFOR Related Headlines

Sep 29, 2025 07:30AM Altimmune names Christophe Arbet-Engels as chief medical officer
Sep 29, 2025 07:30AM Altimmune Appoints Industry Veteran Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer to Drive Next Phase of Clinical Development of Pemvidutide

ALT and XFOR Related Press Releases

Sep 29, 2025 07:30AM Altimmune Appoints Industry Veteran Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer to Drive Next Phase of Clinical Development of Pemvidutide

ALT and XFOR Related SEC Filings